Strategies to measure and improve patient adherence in clinical trials

Pharmaceutical Medicine

Volumn 23, Issue 5-6, 2009, Pages 289-297

  Matsui, Doreen ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ASCORBIC ACID; BRONCHODILATING AGENT; IMMUNOSUPPRESSIVE AGENT;

ARTHRITIS; BLISTER PACK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTAINER; DEVICE; DRUG DETERMINATION; DRUG SELF ADMINISTRATION; GRAFT RECIPIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERACTIVE VOICE RESPONSE SYSTEM; INTERVIEW; LIFESTYLE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MEDLINE; METERED DOSE INHALER; MOBILE PHONE; MONITOR; OBSERVATION; PALATABILITY; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT MONITORING; PERSONAL DIGITAL ASSISTANT; PHARMACY; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; ROBOTICS; SELF REPORT; SMOKING CESSATION; TECHNOLOGY;

EID: 77149173160     PISSN: 11782595     EISSN: 11791993     Source Type: Journal    
DOI: 10.1007/bf03256784     Document Type: Review

References (77)

1. Bonaccorso S, Sturchio JL. Perspectives from the pharmaceutical industry. BMJ 2003; 327: 863-864
2. World Health Organization. Adherence to long-term therapies: evidence for action [online]. Available from URL: http://www.who.int/chp/knowledge/ publications/adherence-full-report.pdf [Accessed 2009 Sep 20]
3. Tilson HH. Adherence or compliance: changes in terminology. Ann Pharmacother 2004; 38: 161-162
4. Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health 2008; 11: 44-47
5. Pullar T. Compliance with drug therapy. Br J Clin Pharmacol 1991; 32: 535-539
6. Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990; 150: 1377-1378
7. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487-497
8. Ellis S, Shumaker S, Sieber W, et al. Adherence to pharmacological interventions: current trends and future directions. Control Clin Trials 2000; 21 Suppl. 5: 218S-25S
9. Vrijens B, Vincze G, Kristanto P, et al. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336: 1114-1117
10. Bloom BS. Daily regimen and compliance with treatment [editorial]. BMJ 2001; 323: 647
11. Morgan SG, Yan L. Persistence with hypertension treatment among community- dwelling BC seniors. Can J Clin Pharmacol 2004; 11: e267-73
12. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantative review of 50 years of research. Med Care 2004; 42: 200-209
13. Pritchard MT, Butow PN, Stevens MM, et al. Understanding medication adherence in pediatric acute lymphoblastic leukemia: a review. J Pediatr Hematol Oncol 2006; 28: 816-823
14. Ruddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 2009; 59: 56-66
15. Fine RN, Becker Y, De Geest S, et al. Nonadherence consensus conference summary report. Am J Transplant 2009; 9: 35-41
16. DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002; 40: 794-811
17. Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006 Jul 1; 333 (7557): 15. Epub 2006 Jun 21
18. StormsW. Clinical trials: are these your patients? JAllergy Clin Immunol 2003; 112 Suppl. 5: S107-11
19. Miller LG, Hays RD. Measuring adherence to antiretroviral medications in clinical trials. HIV Clin Trials 2000; 1: 36-46
20. Boudes P. Drug compliance in therapeutic trials: a review. Control Clin Trials 1998; 19: 257-268
21. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999; 21: 1074-1090
22. Robiner WN. Enhancing adherence in clinical research. Contemp Clin Trials 2005; 26: 59-77
23. International Conference on Harmonization. E8: general considerations for clinical trials [online]. Available from URL: http: //www.ich.org/LOB/ media/MEDIA484.pdf [Accessed 2009 Sep 20]
24. Urquhart J. Role of patient compliance in clinical pharmacokinetics. Clin Pharmacokinet 1994; 27: 202-215
25. Soutter BR, Kennedy MC. Patient compliance assessment in drug trials usage and methods. Aust N Z J Med 1974; 4: 360-364
26. Jayaraman S, Rieder MJ, Matsui DM. Compliance assessment in drug trials: has there been improvement in two decades? Can J Clin Pharmacol 2005; 12 (3): e251-3
27. Matsui D. Drug compliance in pediatrics: clinical and research issues. Pediatr Clin North Am 1997; 44: 1-14
28. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009; 119: 3028-3035
29. Winnick S, Lucas DO, Hartman AL, et al. How do you improve compliance? Pediatrics 2005; 115: e718-24
30. Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med 2008; 31: 213-224
31. Blowey DL, Hebert D, Arbus G, et al. Compliance with cyclosporine in adolescent renal transplant recipients. Pediatr Nephrol 1997; 11: 547-551
32. Lau RCW, Matsui D, Greenberg M, et al. Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia. Med Pediatr Oncol 1998; 30: 85-90
33. McNamara PS, McCormack P, McDonald AJ, et al. Open adherence monitoring using routine data download from an adaptive aerosol delivery nebulizer in children with cystic fibrosis. J Cyst Fibros 2009; 8: 258-263
34. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23: 1296-1310
35. Saini SD, Schoenfeld P, Kaulback K, et al. Effect of medication dosing frequency on adherence in chronic diseases. Am JManag Care 2009; 15: e22-33
36. Richter A, Anton SF, Koch P, et al. The impact of reducing dose frequency on health outcomes. Clin Ther 2003; 25: 2307-2335
37. Hayes TL, Hunt JM, Adami A, et al. An electronic pillbox for continuous monitoring of medication adherence. Proceedings of the 28th IEEE EMBS Annual International Conference. IEEE EngMed Biol Soc 2006 Aug 30-Sep 3; 6400-6403
38. Sackett DL, Haynes RB, Guyatt GH, et al., editors. Helping patients follow the treatments you prescribe. In: Clinical epidemiology: a basic science for clinical medicine. Boston (MA): Little, Brown and Company, 1991: 249-281
39. Stone AA, Shiffman S, Schwartz JE, et al. Patient compliance with paper and electronic diaries. Control Clin Trials 2003; 24: 182-199
40. Kerr T, Walsh J, Lloyd-Smith E, et al. Measuring adherence to highly active antiretroviral therapy: implications for research and practice. Curr HIV/AIDS Rep 2005; 2: 200-205
41. Simmons MS, Nides MA, Rand CS, et al. Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest 2000; 118: 290-295
42. Paschal AM, Hawley SR, St. Romain T, et al. Measures of adherence to epilepsy treatment: review of present practices and recommendations for future directions. Epilepsia 2008; 49: 1115-1122
43. Breath monitor tracks medication adherence. AIDS Patient Care STDS 2008; 22 (5): 437-439
44. Cramer JA. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 1995; 49: 321-327
45. Christensen A, Osterberg LG, Hansen EH. Electronic monitoring of patient adherence to oral antihypertensive medical treatment: a systematic review. J Hypertens 2009; 27: 1540-1551
46. Santschi V, Wuerzner G, Schneider M, et al. Clinical evaluation of IDAS II, a new electronic device enabling drug adherence monitoring. Eur J Clin Pharmacol 2007; 63: 1179-1184
47. Shellmer DA, Zelikovsky N. The challenges of using medication event monitoring technology with pediatric transplant patients. Pediatr Transplant 2007; 11: 422-428
48. Klocke RA. Ethics of monitoring patient adherence: an evolving dilemma [editorial]. Am J Respir Crit Care Med 1994; 149: 286
49. Shumaker SA, Dugan E, Bowen DJ. Enhancing adherence in randomized controlled clinical trials. Control Clin Trials 2000; 21 Suppl. 5: 226S-32S
50. Kastrissios H, Blaschke TF. Medication compliance as a feature in drug development. Annu Rev Pharmacol Toxicol 1997; 37: 451-475
51. Heneghan CJ, Glasziou PP, Perera R. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Sys Rev 2006; (1): CD005025
52. Hughes D. When drugs don't work: economic assessment of enhancing compliance with interventions supported by electronic monitoring devices. Pharmacoeconomics 2007; 25: 621-635
53. Kripalani S, Yao X, Haynes B. Interventions to enhance medication adherence in chronic medical conditions. Arch Intern Med 2007; 167: 540-550
54. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancingmedication adherence. Cochrane Database Sys Rev 2008; (2): CD000011
55. van Dulmen S, Sluijs E, van Dijk L, et al. Furthering patient adherence: a position paper of the international expert forum on patient adherence based on an internet forum discussion [letter]. BMC Health Serv Res 2008; 8: 47
56. Urquhart J. Ascertaining how much compliance is enough with outpatient antibiotic regimens. Postgrad Med J 1992; 68 Suppl. 3: S49-59
57. Bangalore S, Kamalakkannan G, Parker S, et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am JMed 2007; 120: 713-719
58. The Indian Polycap Study (TIPS), Yusuf S, Pais P, Afzal R, et al. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomized trial. Lancet 2009; 373: 1341-1351
59. Rudd P. Medication packaging: simple solutions to nonadherence problems? Clin Pharmacol Ther 1979; 25: 257-265 (Pubitemid 9181038)
60. Huang H, Maguire M, Miller III E, et al. Impact of pill organizers and blister packs on adherence to pill taking in two vitamin supplementation trials. Am J Epidemiol 2000; 152: 780-787
61. Connor J, Rafter N, Rodgers A. Do fixed-dose combination pills or unit-of-use packaging improve adherence?Asystematic review. Bull World Health Organ 2004; 82: 935-939
62. Glass BD, Haywood A, Llewelyn V, et al. Compliance aids and medicine stability: new evidence of quality assurance. Curr Drug Saf 2009; 4: 74-78
63. Wise J, Operario D. Use of electronic reminder devices to improve adherence to antiretroviral therapy: a systematic review. AIDS Patient Care STDS 2008; 22: 495-504
64. Taddeo D, Egedy M, Frappier J. Adherence to treatment in adolescents. Paediatr Child Health 2008; 13: 19-24
65. Naditz A. Medication compliance - helping patients through technology: modern "smart" pillboxes keep memory-short patients on their medical regimen. Telemed J E Health 2008; 14: 875-880
66. Volpp KG, Loewenstein G, Troxel AB, et al. A test of financial incentives to improve warfarin adherence. BMC Health Serv Res 2008; 8: 272
67. Sather BC, Forbes JJ, Starck DJ, et al. Effect of a personal automated dosedispensing system on adherence: a case series. J Am Pharm Assoc 2007; 47: 82-85
68. Cocosila M, Archer N. A framework for mobile healthcare answers to chronically ill outpatient non-adherence. Inform Prim Care 2005; 13: 145-152
69. Krishna S, Boren SA, Balas EA. Healthcare via cell phones: a systematic review. Telemed J E Health 2009; 15: 231-240
70. Cocosila M, Archer N, Haynes RB, et al. Can wireless text messaging improve adherence to preventive activities? Results of a randomized controlled trial. Int J Med Inform 2009; 78: 230-238
71. Franklin VL, Waller A, Pagliari C, et al.Arandomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes. Diabet Med 2006; 23: 1332-1338
72. Miloh T, Annunziato R, ArnonR, et al. Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging. Pediatrics 2009; 124: e844-50
73. Safren SA, Hendriksen ES, Desousa N, et al. Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care 2003; 15: 787-793
74. Takacs B, Hanak D. A prototype home robot with an ambient facial interface to improve drug compliance. J Telemed Telecare 2008; 14: 393-395
75. Koop A, Mosges R. The use of handheld computers in clinical trials. Control Clin Trials 2002; 23: 469-480
76. Sahm L, MacCurtain A, Hayden J, et al. Electronic reminders to improve medication adherence: are they acceptable to the patient? Pharm World Sci 2009; 31: 627-629
77. Reidel K, Tamblyn R, Patel V, et al. Pilot study of an interactive voice response system to improve medication refill compliance. BMC Med Inform Decis Mak 2008; 8: 46